Recruiting

Observational Study

Sponsor:

Vanderbilt-Ingram Cancer Center

Code:

NCT06482957

Conditions

Sarcoma

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Interventions

Surveys

Blood Collection

Saliva Collection

Urine Collection

Stool Collection

Study Details

Brief summary:

This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.

Conditions

Sarcoma

Study ID

NCT06482957

Start date

Apr 1, 2022

Status verified date

Sep, 2025

Completion date

Apr, 2029

Anticipated

Primary completion date

Apr, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Patients at any age with a history of sarcoma, with or without evidence of a persistent disease

• For pediatric patients

  • Parent/primary caregiver of patient
  • Sibling of patient aged 8 years or older

Study Design

Enrollment

2100 participants

Anticipated

Interventions and Outcome Measures

Arms

Observational

Patients monitor physical activity, sedentary behavior, heart rate and sleep wearing a FitBit device, undergo blood urine, stool and/or saliva sample collection, complete surveys and have medical records reviewed throughout study.

Interventions

Surveys

Complete surveys

Blood Collection

Undergo blood collection

Saliva Collection

Undergo salvia collection

Urine Collection

Undergo urine collection

Stool Collection

Undergo stool collection

Tissue collection

Undergo tissue collection

Physical Activity Monitoring

FitBit will be worn to track physical activity

Primary outcome measure

  • Impact of disease on adverse oncologic outcomes [ Time Frame: Approximately six years ]
  • Impact of treatment on adverse oncologic outcomes [ Time Frame: Approximately six years ]
  • Impact of sociodemographic contributors on adverse oncologic outcomes [ Time Frame: Approximately six years ]
  • Impact of lifestyle contributors on adverse oncologic outcomes [ Time Frame: Approximately six years ]

Central Contacts and Locations

Central contacts

Vanderbilt-Ingram Services for Timely Access

800-811-8480cip@vumc.org

Locations

Vanderbilt University/Ingram Cancer Center

Recruiting

Nashville, Tennessee, United States, 37203

Contacts

Vanderbilt-Ingram Service for Timely Access

800-811-8480cip@vumc.org

Principal Investigator:

Debra Friedman, MD

More Information

Sponsor

Vanderbilt-Ingram Cancer Center

Last update posted

Sep 19, 2025

Last verified

Sep, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Vanderbilt-Ingram Cancer Center on 2025-09-19.